RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
WHO-Leitlinie zur Prävention, Diagnostik und Behandlung von Unfruchtbarkeit
Piso, B., Sommer, I., & Gartlehner, G. (2026). WHO-Leitlinie zur Prävention, Diagnostik und Behandlung von Unfruchtbarkeit. Gesundheitswesen. Advance online publication. https://doi.org/10.1055/a-2923-8257
BACKGROUND: Infertility affects approximately one in six people of reproductive age worldwide and represents a major global health issue, regardless of world region or income level. It limits the realization of individuals' desire to have children, thereby underscoring the importance of high-quality fertility care.
METHOD: The guideline was developed by WHO in accordance with WHO standards. It. The executive summary was translated into German by the WHO Collaborating Centre for Evidence-based Medicine at the University of Continuing Education Krems (Austria).
RESULTS: In addition to general good practice recommendations for the management of infertility, the guideline includes four recommendations on prevention, eleven on diagnosis, and 24 on the treatment of infertility. The diagnostic and treatment recommendations further distinguish between female, male, and unexplained infertility.
CONCLUSIONS: This guideline is the first WHO guideline on the prevention, diagnosis, and treatment of infertility. It aims to improve the implementation of evidence-based interventions related to infertility.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.
